{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:53:16Z","timestamp":1778899996434,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00430-023-00770-z","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T16:46:26Z","timestamp":1686069986000},"page":"271-278","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pentraxin 3, a serum biomarker in human T-cell lymphotropic virus type-1-associated myelopathy patients and asymptomatic carriers"],"prefix":"10.1007","volume":"212","author":[{"given":"Motahareh","family":"Manzarinejad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohreh","family":"Vahidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Boostani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Khadem-Rezaiyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houshang","family":"Rafatpanah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7421-3218","authenticated-orcid":false,"given":"Fariba","family":"Zemorshidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,6]]},"reference":[{"issue":"3","key":"770_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","volume":"15","author":"A Gessain","year":"2012","unstructured":"Gessain A, Cassar O (2012) Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol 15(3):388. https:\/\/doi.org\/10.3389\/fmicb.2012.00388","journal-title":"Front Microbiol"},{"issue":"3","key":"770_CR2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jcv.2011.07.004","volume":"52","author":"H Rafatpanah","year":"2011","unstructured":"Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, Ahmadi S, Sohgandi L, Azarpazhooh MR, Rezaee SA, Farid R, Bazarbachi A (2011) High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J Clin Virol 52(3):172\u2013176. https:\/\/doi.org\/10.1016\/j.jcv.2011.07.004","journal-title":"J Clin Virol"},{"issue":"5","key":"770_CR3","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s13365-020-00881-w","volume":"26","author":"S Nozuma","year":"2020","unstructured":"Nozuma S, Kubota R, Jacobson S (2020) Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy\/tropical spastic paraparesis. J Neurovirol 26(5):652\u2013663. https:\/\/doi.org\/10.1007\/s13365-020-00881-w","journal-title":"J Neurovirol"},{"issue":"6","key":"770_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00430-019-00625-6","volume":"208","author":"A Mohammadi","year":"2019","unstructured":"Mohammadi A, Fazeli B, Poursina Z, Tehranian F, Vakili V, Boostani R, Rafatpanah H (2019) HTLV-1-infected asymptomatic carriers compared to HAM\/TSP patients over-express the apoptosis- and cytotoxicity-related molecules. Med Microbiol Immunol 208(6):835\u2013844. https:\/\/doi.org\/10.1007\/s00430-019-00625-6","journal-title":"Med Microbiol Immunol"},{"issue":"12","key":"770_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12985-015-0398-x","volume":"12","author":"ES Gudo","year":"2015","unstructured":"Gudo ES, Silva-Barbosa SD, Linhares-Lacerda L, Ribeiro-Alves M, Real SC, Bou-Habib DC, Savino W (2015) HAM\/TSP-derived HTLV-1-infected T cell lines promote morphological and functional changes in human astrocytes cell lines: possible role in the enhanced T cells recruitment into central nervous system. Virol J 12(12):165. https:\/\/doi.org\/10.1186\/s12985-015-0398-x","journal-title":"Virol J"},{"issue":"10","key":"770_CR6","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.3390\/v14102146","volume":"14","author":"NL Freitas","year":"2022","unstructured":"Freitas NL, Gomes YCP, Souza FDS, Torres RC, Echevarria-Lima J, Leite ACCB, Lima MASD, Ara\u00fajo AQC, Silva MTT, Esp\u00edndola OM (2022) Lessons from the cerebrospinal fluid analysis of HTLV-1-infected individuals: biomarkers of inflammation for HAM\/TSP development. Viruses 14(10):2146. https:\/\/doi.org\/10.3390\/v14102146","journal-title":"Viruses"},{"issue":"4","key":"770_CR7","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.esxm.2018.07.002","volume":"6","author":"AL Lopes Martins","year":"2018","unstructured":"Lopes Martins AL, Rios Grassi MF, de Aquino FA, Lacerda Araujo JP, Paixao TS, Galv\u00e3o-Castro B, Boa-Sorte N (2018) Human T-lymphotropic virus-1-associated myelopathy\/tropical spastic paraparesis is associated with sexual dysfunction in infected women of reproductive age. Sex Med 6(4):324\u2013331. https:\/\/doi.org\/10.1016\/j.esxm.2018.07.002. (Epub 2018 Sep 1)","journal-title":"Sex Med"},{"issue":"7","key":"770_CR8","doi-asserted-by":"publisher","first-page":"992","DOI":"10.22038\/ijbms.2021.50821.11569","volume":"24","author":"N Hatatian","year":"2021","unstructured":"Hatatian N, Bosstani R, Mohammadi A, Mehraban S, Mahdifar M, Zemorshidi F, Mozhgani SH, Haji Ghadimi A, Foroughipour M, Rafatpanah H (2021) Evaluation of interleukin-32 and cyclooxygenase-2 expression in HAM\/TSP patients and HTLV-1 asymptomatic carriers. Iran J Basic Med Sci 24(7):992\u2013996. https:\/\/doi.org\/10.22038\/ijbms.2021.50821.11569","journal-title":"Iran J Basic Med Sci"},{"key":"770_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.cellimm.2018.09.009","volume":"334","author":"M Guerra","year":"2018","unstructured":"Guerra M, Luna T, Souza A, Amorim C, Carvalho NB, Carvalho L, Tanajura D, Cardoso LS, Carvalho EM, Santos S (2018) Local and systemic production of proinflammatory chemokines in the pathogenesis of HAM\/TSP. Cell Immunol 334:70\u201377. https:\/\/doi.org\/10.1016\/j.cellimm.2018.09.009","journal-title":"Cell Immunol"},{"key":"770_CR10","doi-asserted-by":"publisher","unstructured":"Souza FDS, Freitas NL, Gomes YCP, Torres RC, Echevarria-Lima J, da Silva-Filho IL, Leite ACCB, de Lima MASD, da Silva MTT, Ara\u00fajo AQC, Esp\u00edndola OM. Following the clues: usefulness of biomarkers of neuroinflammation and neurodegeneration in the investigation of HTLV-1-associated myelopathy progression. Front Immunol. 2021;12:737941. https:\/\/doi.org\/10.3389\/fimmu.2021.737941","DOI":"10.3389\/fimmu.2021.737941"},{"issue":"10","key":"770_CR11","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3389\/fneur.2019.01365","volume":"10","author":"L Yi","year":"2020","unstructured":"Yi L, Tang J, Shi C, Zhang T, Li J, Guo F, Zhang W (2020) Pentraxin 3, TNF-\u03b1, and LDL-C are associated with carotid artery stenosis in patients with ischemic stroke. Front Neurol 10(10):1365. https:\/\/doi.org\/10.3389\/fneur.2019.01365","journal-title":"Front Neurol"},{"key":"770_CR12","doi-asserted-by":"publisher","unstructured":"Qi S, Zhao F, Li Z, Liang F, Yu S (2020) Silencing of PTX3 alleviates LPS-induced inflammatory pain by regulating TLR4\/NF-\u03baB signaling pathway in mice. Biosci Rep 40(2):BSR20194208. https:\/\/doi.org\/10.1042\/BSR20194208","DOI":"10.1042\/BSR20194208"},{"issue":"3","key":"770_CR13","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/eji.201545950","volume":"46","author":"K Ummenthum","year":"2016","unstructured":"Ummenthum K, Peferoen LA, Finardi A, Baker D, Pryce G, Mantovani A, Bsibsi M, Bottazzi B, Peferoen-Baert R, van der Valk P, Garlanda C, Kipp M, Furlan R, van Noort JM, Amor S (2016) Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease. Eur J Immunol 46(3):701\u2013711. https:\/\/doi.org\/10.1002\/eji.201545950","journal-title":"Eur J Immunol"},{"issue":"9","key":"770_CR14","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.4049\/jimmunol.1002035","volume":"186","author":"F Moalli","year":"2011","unstructured":"Moalli F, Paroni M, V\u00e9liz Rodriguez T, Riva F, Polentarutti N, Bottazzi B, Valentino S, Mantero S, Nebuloni M, Mantovani A, Bragonzi A, Garlanda C (2011) The therapeutic potential of the humoral pattern recognition molecule PTX3 in chronic lung infection caused by Pseudomonas aeruginosa. J Immunol 186(9):5425\u20135434. https:\/\/doi.org\/10.4049\/jimmunol.1002035","journal-title":"J Immunol"},{"issue":"12","key":"770_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12974-014-0227-y","volume":"24","author":"B Rodriguez-Grande","year":"2015","unstructured":"Rodriguez-Grande B, Varghese L, Molina-Holgado F, Rajkovic O, Garlanda C, Denes A, Pinteaux E (2015) Pentraxin 3 mediates neurogenesis and angiogenesis after cerebral ischaemia. J Neuroinflamm 24(12):15. https:\/\/doi.org\/10.1186\/s12974-014-0227-y","journal-title":"J Neuroinflamm"},{"issue":"1\u20132","key":"770_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/s0165-5728(00)00214-9","volume":"106","author":"N Polentarutti","year":"2000","unstructured":"Polentarutti N, Bottazzi B, Di Santo E, Blasi E, Agnello D, Ghezzi P, Introna M, Bartfai T, Richards G, Mantovani A (2000) Inducible expression of the long pentraxin PTX3 in the central nervous system. J Neuroimmunol 106(1\u20132):87\u201394. https:\/\/doi.org\/10.1016\/s0165-5728(00)00214-9","journal-title":"J Neuroimmunol"},{"issue":"1","key":"770_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/s0306-4522(01)00177-4","volume":"105","author":"T Ravizza","year":"2001","unstructured":"Ravizza T, Moneta D, Bottazzi B, Peri G, Garlanda C, Hirsch E, Richards GJ, Mantovani A, Vezzani A (2001) Dynamic induction of the long pentraxin PTX3 in the CNS after limbic seizures: evidence for a protective role in seizure-induced neurodegeneration. Neuroscience 105(1):43\u201353. https:\/\/doi.org\/10.1016\/s0306-4522(01)00177-4","journal-title":"Neuroscience"},{"issue":"13","key":"770_CR18","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1002\/mds.23871","volume":"26","author":"HW Lee","year":"2011","unstructured":"Lee HW, Choi J, Suk K (2011) Increases of pentraxin 3 plasma levels in patients with Parkinson\u2019s disease. Mov Disord 26(13):2364\u20132370. https:\/\/doi.org\/10.1002\/mds.23871","journal-title":"Mov Disord"},{"issue":"10","key":"770_CR19","doi-asserted-by":"publisher","first-page":"e24371","DOI":"10.1371\/journal.pone.0024371","volume":"6","author":"MA Bourgeois","year":"2011","unstructured":"Bourgeois MA, Denslow ND, Seino KS, Barber DS, Long MT (2011) Gene expression analysis in the thalamus and cerebrum of horses experimentally infected with West Nile virus. PLoS ONE 6(10):e24371. https:\/\/doi.org\/10.1371\/journal.pone.0024371","journal-title":"PLoS ONE"},{"issue":"4","key":"770_CR20","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s10096-019-03767-w","volume":"39","author":"M Zatta","year":"2020","unstructured":"Zatta M, Di Bella S, Bottazzi B, Rossi F, D\u2019Agaro P, Segat L, Fabbiani M, Mantovani A, Luzzati R (2020) Determination of pentraxin 3 levels in cerebrospinal fluid during central nervous system infections. Eur J Clin Microbiol Infect Dis 39(4):665\u2013670. https:\/\/doi.org\/10.1007\/s10096-019-03767-w","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"770_CR21","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2340\/16501977-0235","volume":"40","author":"T Paternostro-Sluga","year":"2008","unstructured":"Paternostro-Sluga T, Grim-Stieger M, Posch M, Schuhfried O, Vacariu G, Mittermaier C, Bittner C, Fialka-Moser V (2008) Reliability and validity of the Medical Research Council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsy. J Rehabil Med 40(8):665\u2013671. https:\/\/doi.org\/10.2340\/16501977-0235","journal-title":"J Rehabil Med"},{"key":"770_CR22","doi-asserted-by":"crossref","unstructured":"Charalambous CP (2014) Interrater reliability of a modified Ashworth scale of muscle spasticity. Classic papers in orthopaedics. Springer, Berlin, pp 415\u2013417","DOI":"10.1007\/978-1-4471-5451-8_105"},{"issue":"Suppl 1","key":"770_CR23","first-page":"242","volume":"39","author":"S Izumo","year":"1988","unstructured":"Izumo S, Usuku K, Osame M, Arimura K, Igata A (1988) Effect of alpha-interferon treatment on HTLV-I associated myelopathy (HAM). Neurology 39(Suppl 1):242","journal-title":"Neurology"},{"issue":"4","key":"770_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00430-017-0506-1","volume":"206","author":"S Ramezani","year":"2017","unstructured":"Ramezani S, Shirdel A, Rafatpanah H, Akbarin MM, Tarokhian H, Rahimi H, Bari A, Jahantigh HR, Rezaee SA (2017) Assessment of HTLV-1 proviral load, LAT, BIM, c-FOS and RAD51 gene expression in adult T cell leukemia\/lymphoma. Med Microbiol Immunol 206(4):327\u2013335. https:\/\/doi.org\/10.1007\/s00430-017-0506-1","journal-title":"Med Microbiol Immunol"},{"issue":"1","key":"770_CR25","doi-asserted-by":"publisher","first-page":"18340","DOI":"10.1038\/s41598-019-54910-8","volume":"9","author":"SM Staubli","year":"2019","unstructured":"Staubli SM, Sch\u00e4fer J, Rosenthal R, Zeindler J, Oertli D, Nebiker CA (2019) The role of CRP and Pentraxin 3 in the prediction of systemic inflammatory response syndrome and death in acute pancreatitis. Sci Rep 9(1):18340. https:\/\/doi.org\/10.1038\/s41598-019-54910-8","journal-title":"Sci Rep"},{"issue":"4","key":"770_CR26","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s13760-013-0194-6","volume":"113","author":"A Shoeibi","year":"2013","unstructured":"Shoeibi A, Rafatpanah H, Azarpazhooh A, Mokhber N, Hedayati-Moghaddam MR, Amiri A, Hashemi P, Foroghipour M, Hoseini RF, Bazarbachi A, Azarpazhooh MR (2013) Clinical features of HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in northeast Iran. Acta Neurol Belg 113(4):427\u2013433. https:\/\/doi.org\/10.1007\/s13760-013-0194-6","journal-title":"Acta Neurol Belg"},{"issue":"10","key":"770_CR27","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1182\/blood-2006-03-009266","volume":"108","author":"S Bozza","year":"2006","unstructured":"Bozza S, Bistoni F, Gaziano R, Pitzurra L, Zelante T, Bonifazi P, Perruccio K, Bellocchio S, Neri M, Iorio AM, Salvatori G, De Santis R, Calvitti M, Doni A, Garlanda C, Mantovani A, Romani L (2006) Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation. Blood 108(10):3387\u20133396. https:\/\/doi.org\/10.1182\/blood-2006-03-009266","journal-title":"Blood"},{"issue":"10","key":"770_CR28","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3389\/fimmu.2019.00794","volume":"12","author":"R Porte","year":"2019","unstructured":"Porte R, Davoudian S, Asgari F, Parente R, Mantovani A, Garlanda C, Bottazzi B (2019) The long pentraxin PTX3 as a humoral innate immunity functional player and biomarker of infections and sepsis. Front Immunol 12(10):794. https:\/\/doi.org\/10.3389\/fimmu.2019.00794","journal-title":"Front Immunol"},{"issue":"7","key":"770_CR29","doi-asserted-by":"publisher","first-page":"43045","DOI":"10.1038\/srep43045","volume":"20","author":"IT Vengen","year":"2017","unstructured":"Vengen IT, Enger TB, Videm V, Garred P (2017) Pentraxin 3, ficolin-2 and lectin pathway associated serine protease MASP-3 as early predictors of myocardial infarction\u2014the HUNT2 study. Sci Rep 20(7):43045. https:\/\/doi.org\/10.1038\/srep43045","journal-title":"Sci Rep"},{"issue":"1","key":"770_CR30","doi-asserted-by":"publisher","first-page":"9616","DOI":"10.1038\/s41598-021-89032-7","volume":"11","author":"M Oggioni","year":"2021","unstructured":"Oggioni M, Mercurio D, Minuta D, Fumagalli S, Popiolek-Barczyk K, Sironi M, Ciechanowska A, Ippati S, De Blasio D, Perego C, Mika J, Garlanda C, De Simoni MG (2021) Long pentraxin PTX3 is upregulated systemically and centrally after experimental neurotrauma, but its depletion leaves unaltered sensorimotor deficits or histopathology. Sci Rep 11(1):9616. https:\/\/doi.org\/10.1038\/s41598-021-89032-7","journal-title":"Sci Rep"},{"issue":"7","key":"770_CR31","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1177\/1352458512457845","volume":"19","author":"H Wang","year":"2013","unstructured":"Wang H, Wang K, Wang C, Zhong X, Qiu W, Hu X (2013) Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica. Mult Scler 19(7):926\u2013931. https:\/\/doi.org\/10.1177\/1352458512457845","journal-title":"Mult Scler"},{"issue":"2","key":"770_CR32","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.atherosclerosis.2011.11.036","volume":"220","author":"WS Ryu","year":"2012","unstructured":"Ryu WS, Kim CK, Kim BJ, Kim C, Lee SH, Yoon BW (2012) Pentraxin 3: a novel and independent prognostic marker in ischemic stroke. Atherosclerosis 220(2):581\u2013586. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.11.036","journal-title":"Atherosclerosis"},{"issue":"4","key":"770_CR33","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00134-010-1752-5","volume":"36","author":"T Mauri","year":"2010","unstructured":"Mauri T, Bellani G, Patroniti N, Coppadoro A, Peri G, Cuccovillo I, Cugno M, Iapichino G, Gattinoni L, Pesenti A, Mantovani A (2010) Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality. Intensive Care Med 36(4):621\u2013629. https:\/\/doi.org\/10.1007\/s00134-010-1752-5","journal-title":"Intensive Care Med"},{"issue":"12","key":"770_CR34","doi-asserted-by":"publisher","first-page":"e1007469","DOI":"10.1371\/journal.ppat.1007469","volume":"14","author":"V Ciancarella","year":"2018","unstructured":"Ciancarella V, Lembo-Fazio L, Paciello I, Bruno AK, Jaillon S, Berardi S, Barbagallo M, Meron-Sudai S, Cohen D, Molinaro A, Rossi G, Garlanda C, Bernardini ML (2018) Role of a fluid-phase PRR in fighting an intracellular pathogen: PTX3 in Shigella infection. PLoS Pathog 14(12):e1007469. https:\/\/doi.org\/10.1371\/journal.ppat.1007469","journal-title":"PLoS Pathog"},{"issue":"1","key":"770_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.micinf.2004.09.004","volume":"7","author":"A Azzurri","year":"2005","unstructured":"Azzurri A, Sow OY, Amedei A, Bah B, Diallo S, Peri G, Benagiano M, D\u2019Elios MM, Mantovani A, Del Prete G (2005) IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect 7(1):1\u20138. https:\/\/doi.org\/10.1016\/j.micinf.2004.09.004","journal-title":"Microbes Infect"},{"issue":"6","key":"770_CR36","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jinf.2009.04.004","volume":"58","author":"JF Wagenaar","year":"2009","unstructured":"Wagenaar JF, Goris MG, Gasem MH, Isbandrio B, Moalli F, Mantovani A, Boer KR, Hartskeerl RA, Garlanda C, van Gorp EC (2009) Long pentraxin PTX3 is associated with mortality and disease severity in severe Leptospirosis. J Infect 58(6):425\u2013432. https:\/\/doi.org\/10.1016\/j.jinf.2009.04.004","journal-title":"J Infect"},{"issue":"1","key":"770_CR37","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/SHK.0b013e31817fd543","volume":"31","author":"T Sprong","year":"2009","unstructured":"Sprong T, Peri G, Neeleman C, Mantovani A, Signorini S, van der Meer JW, van Deuren M (2009) Pentraxin 3 and C-reactive protein in severe meningococcal disease. Shock 31(1):28\u201332. https:\/\/doi.org\/10.1097\/SHK.0b013e31817fd543","journal-title":"Shock"},{"issue":"4","key":"770_CR38","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/jmv.20397","volume":"76","author":"AT Mairuhu","year":"2005","unstructured":"Mairuhu AT, Peri G, Setiati TE, Hack CE, Koraka P, Soemantri A, Osterhaus AD, Brandjes DP, van der Meer JW, Mantovani A, van Gorp EC (2005) Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections. J Med Virol 76(4):547\u2013552. https:\/\/doi.org\/10.1002\/jmv.20397","journal-title":"J Med Virol"},{"issue":"1","key":"770_CR39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/ppul.23199","volume":"51","author":"HS Kim","year":"2016","unstructured":"Kim HS, Won S, Lee EK, Chun YH, Yoon JS, Kim HH, Kim JT (2016) Pentraxin 3 as a clinical marker in children with lower respiratory tract infection. Pediatr Pulmonol 51(1):42\u201348. https:\/\/doi.org\/10.1002\/ppul.23199","journal-title":"Pediatr Pulmonol"},{"issue":"12","key":"770_CR40","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/MPH.0b013e318180bc1d","volume":"30","author":"E Biagi","year":"2008","unstructured":"Biagi E, Col M, Migliavacca M, Dell\u2019Oro M, Silvestri D, Montanelli A, Peri G, Mantovani A, Biondi A, Rossi MR (2008) PTX3 as a potential novel tool for the diagnosis and monitoring of pulmonary fungal infections in immuno-compromised pediatric patients. J Pediatr Hematol Oncol 30(12):881\u2013885. https:\/\/doi.org\/10.1097\/MPH.0b013e318180bc1d","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"770_CR41","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1515\/cclm-2012-0459","volume":"51","author":"SJ Kao","year":"2013","unstructured":"Kao SJ, Yang HW, Tsao SM, Cheng CW, Bien MY, Yu MC, Bai KJ, Yang SF, Chien MH (2013) Plasma long pentraxin 3 (PTX3) concentration is a novel marker of disease activity in patients with community-acquired pneumonia. Clin Chem Lab Med 51(4):907\u2013913. https:\/\/doi.org\/10.1515\/cclm-2012-0459","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"770_CR42","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.immuni.2014.02.015","volume":"40","author":"S Jaillon","year":"2014","unstructured":"Jaillon S, Moalli F, Ragnarsdottir B, Bonavita E, Puthia M, Riva F, Barbati E, Nebuloni M, Cvetko Krajinovic L, Markotic A, Valentino S, Doni A, Tartari S, Graziani G, Montanelli A, Delneste Y, Svanborg C, Garlanda C, Mantovani A (2014) The humoral pattern recognition molecule PTX3 is a key component of innate immunity against urinary tract infection. Immunity 40(4):621\u2013632. https:\/\/doi.org\/10.1016\/j.immuni.2014.02.015","journal-title":"Immunity"},{"issue":"3","key":"770_CR43","first-page":"268","volume":"16","author":"R Vakili","year":"2013","unstructured":"Vakili R, Sabet F, Aahmadi S, Boostani R, Rafatpanah H, Shamsian A, Rezaee SA (2013) Human T-lymphotropic Virus Type I (HTLV-I) proviral load and clinical features in Iranian HAM\/TSP patients: comparison of HTLV-I proviral load in HAM\/TSP patients. Iran J Basic Med Sci 16(3):268\u2013272","journal-title":"Iran J Basic Med Sci"},{"issue":"7","key":"770_CR44","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1073\/pnas.96.7.3848","volume":"96","author":"KJ Jeffery","year":"1999","unstructured":"Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, Bunce M, Ogg GS, Welsh KI, Weber JN, Lloyd AL, Nowak MA, Nagai M, Kodama D, Izumo S, Osame M, Bangham CR (1999) HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci USA 96(7):3848\u20133853. https:\/\/doi.org\/10.1073\/pnas.96.7.3848","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"770_CR45","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.4049\/jimmunol.180.5.3391","volume":"180","author":"PC Reading","year":"2008","unstructured":"Reading PC, Bozza S, Gilbertson B, Tate M, Moretti S, Job ER, Crouch EC, Brooks AG, Brown LE, Bottazzi B, Romani L, Mantovani A (2008) Antiviral activity of the long chain pentraxin PTX3 against influenza viruses. J Immunol 180(5):3391\u20133398. https:\/\/doi.org\/10.4049\/jimmunol.180.5.3391","journal-title":"J Immunol"},{"issue":"2","key":"770_CR46","doi-asserted-by":"publisher","first-page":"e1004649","DOI":"10.1371\/journal.ppat.1004649","volume":"11","author":"SS Foo","year":"2015","unstructured":"Foo SS, Chen W, Taylor A, Sheng KC, Yu X, Teng TS, Reading PC, Blanchard H, Garlanda C, Mantovani A, Ng LF, Herrero LJ, Mahalingam S (2015) Role of pentraxin 3 in shaping arthritogenic alphaviral disease: from enhanced viral replication to immunomodulation. PLoS Pathog. 11(2):e1004649. https:\/\/doi.org\/10.1371\/journal.ppat.1004649. (Erratum in: PLoS Pathog. 2015 Apr;11(4):e1004797)","journal-title":"PLoS Pathog."}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-023-00770-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00430-023-00770-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-023-00770-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T04:06:57Z","timestamp":1690344417000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00430-023-00770-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,6]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["770"],"URL":"https:\/\/doi.org\/10.1007\/s00430-023-00770-z","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,6]]},"assertion":[{"value":"4 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the ethics committee of Mashhad University of Medical Sciences with approval code IR.MUMS.MEDICAL.REC.1399.44.7. All the participants were informed about the study procedure and provided written consent before they participated in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}